« Return to News | CROs/Service Providers | R&D Trends

Top Stories for the Week of August 6th 2007

Friday, August 10, 2007 07:11 AM

Top News

 

Canadian Health Authorities Helping to Keep Phase I Research in Canada

With an influx of emerging biotechnology companies—more than 80 to date—Alberta would seem a place for an early phase clinical trials market to take hold. Yet until recently there were no phase I units in this province of three million people. Now in partnership with the city of Edmonton, the Northern Alberta Clinical Trials Research Center (NACTRC) has launched Albertas first phase I unit, staying true to its stated mission to foster more clinical research in the region.

Taratec Acquired by Patni Computer Systems

Mumbai-based information technology (IT) services and software provider Patni Computer Systems has acquired Taratec, a life sciences regulatory and IT consulting firm based in Bridgewater, N.J. The firm was acquired for $27.2 million. Taratec has a staff of 150 and annual revenues of more than $20 million.

Other breaking news...      

Company Profile: An interview with Hans Ardn, president,and Monica Lizano, medical director, Bio-Trials Clinical Research

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.